GeoffreyMukasaMukwayaMD

PubMed

• 25 citations
  T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib ...
  Kevin L. Winthrop, Neil J. Korman, William Abramovits, Scott T. Rottinghaus, Huaming Tan, Annie Gardner, Geoffrey Mukwaya, Mandeep Kaur, Hernan Valdez> ;Journal of the American Academy of Dermatology. 2018 Jun 1
• 36 citations
  Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment.
  Hans Jürgen Stellbrink, Eric L E Fevre, Andrew Carr, Michael S. Saag, Geoffrey Mukwaya, Silvia Nozza, Srinivas Rao Valluri, Manoli Vourvahis, Alex R. Rinehart, Lynn Mc...> ;AIDS. 2016 May 15
• 1 citations
  Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiret...
  Jùrgen K Rockstroch, Vicente Soriano, Frank Plonski, Meena Bansal, Gerd Fätkenheuer, Catherine B Small, David M Asmuth, Gilles Pialoux, Geoffrey Mukwaya, Shyla Jaganna...> ;HIV Clinical Trials. 2015 Nov 1
• 3 citations
  Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral a...
  Juergen K Rockstroh, Vicente Soriano, Frank Plonski, Meena Bansal, Gerd Fätkenheuer, Catherine B Small, David M Asmuth, Gilles Pialoux, Geoffrey Mukwaya, Shyla Jaganna...> ;HIV Clinical Trials. 2015 Apr 30
• 8 citations
  The maraviroc expanded access program — safety and efficacy data from an open-label study
  Adriano Lazzarin, Jacques Reynes, Jean-Michel Molina, Srinivas Rao Valluri, Geoffrey Mukwaya, Jayvant Heera, Charles Craig, Elna van der Ryst, Juan Sierra-Madero> ;HIV Clinical Trials. 2015 Feb 5
• Single-dose pharmacokinetics, safety, and tolerability of modified-release formulations of lersivirine in healthy subjects.
  Manoli Vourvahis, Ronnie Wang, Laure Mendes da Costa, Cunshan Wang, Barry Weatherley, Geoffrey Mukwaya, Margaret Tawadrous, Jayvant Heera> ;Clinical Pharmacology in Drug Development. 2014 Nov 1
• 25 citations
  Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings
  David A. Cooper, Jayvant Heera, Prudence Ive, Mariette E. Botes, Edwin DeJesus, Robert Burnside, Nathan Clumeck, Sharon Walmsley, Adriano Lazzarin, Geoffrey Mukwaya, M...> ;AIDS. 2014 Mar 13
• 32 citations
  Five-Year Safety Evaluation of Maraviroc in HIV-1-Infected Treatment-Experienced Patients
  Roy M. Gulick, Gerd Fätkenheuer, Robert Burnside, W. David Hardy, Mark Nelson, James Goodrich, Geoffrey Mukwaya, Simon Portsmouth, Jayvant Heera> ;Journal of Acquired Immune Deficiency Syndromes. 2014 Jan 1
• 14 citations
  Safety Profile of Maraviroc in Patients Coinfected With HIV-1 and Hepatitis B or C Included in the Maraviroc Expanded Access Program
  Adriano Lazzarin, Soe Than, Srinivas Rao Valluri, Jayvant Heera, Geoffrey Mukwaya> ;HIV Clinical Trials. 2012 Mar 1
• 69 citations
  Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial
  Joseph Gathe, David A. Cooper, Charles Farthing, Dushyantha Jayaweera, Dorece Norris, Gerald Pierone, Corklin R. Steinhart, Benoit Trottier, Sharon Walmsley, Cassy Wor...> ;Clinical Infectious Diseases. 2006 Nov 15
• 46 citations
  Interaction of Ritonavir-Boosted Tipranavir with Loperamide Does Not Result in Loperamide-Associated Neurologic Side Effects in Healthy Volunteers
  Geoffrey Mukwaya, Thomas R. MacGregor, David D. Hoelscher, Thomas A. Heming, Daniel Legg, Kelli Kavanaugh, Phillip Johnson, John P. Sabo, Scott McCallister> ;Antimicrobial Agents and Chemotherapy. 2005 Dec 1
• 88 citations
  Treatment of Scedosporium apiospermum Brain Abscesses with Posaconazole
  Ingo K. Mellinghoff, Drew J. Winston, Geoffrey Mukwaya, Gary J. Schiller> ;Clinical Infectious Diseases. 2002 Jun 15
• 3 citations
  Serum immunoreactive erythropoietin levels and associated factors amongst HIV-infected children.
  Upton Allen, Susan M. King, Martin P. Gomez, Normand Lapointe, Jack C. Forbes, Anona Thorne, Melanie-Ann Kirby, Janet Bowker, Janet Raboud, Joel Singer, Geoffrey Mukwa...> ;AIDS. 1998 Oct 1
• 27 citations
  Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
  Pierre-Marie Girard, Olivier Bouchaud, Agnès Goetschel, Geoffrey Mukwaya, Gerald Eestermans, Michael W. Ross, Willy Rozenbaum, Saimot Ag> ;AIDS. 1996 Jun 1
• 10 citations
  Suppurative infections in children caused by non-beta-hemolytic members of the Streptococcus milleri group.
  Donna S. Jackson, David F. Welch, Denise A. Pickett, Geoffrey M. Mukwaya, Thomas L. Kuhls> ;The Pediatric Infectious Disease Journal. 1995 Jan 1
• 55 citations
  Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.
  J C Christenson, D F Welch, G M Mukwaya, Michael J. Muszynski, R E Weaver, D J Brenner> ;Journal of Clinical Microbiology. 1989 Feb 1
• 40 citations
  Candida lusitaniae: an emerging human pathogen
  John C. Christenson, Arthur Guruswamy, Geoffrey M. Mukwaya, Philip J. Rettig> ;The Pediatric Infectious Disease Journal. 1987 Aug 1
• Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
  Gill, P. S., Wernz, J., Scadden, D. T., Cohen, P., Mukwaya, G. M., von Roenn, J. H., Jacobs, M., Kempin, S., Silverberg, I., Gonzales, G., Rarick, M. U., Myers, A. M.,...> ;J Clin Oncol. 1996 Aug
• Subgrouping of Pseudomonas cepacia by cellular fatty acid composition.
  Mukwaya, G. M., Welch, D. F.> ;J Clin Microbiol. 1989 Dec
• Thermophilic sulfate reduction in hydrothermal sediment of lake tanganyika, East Africa.
  Elsgaard, L., Prieur, D., Mukwaya, G. M., Jørgensen, B. B.> ;Appl Environ Microbiol. 1994 May
• Join now to see all